Chamber and committees

The Scottish Cardiac Audit Programme publishes annual data on incidence, cardiac interventions and patient outcomes across Scotland. The most recent reports are available here; Scottish Cardiac Audit Programme report 2023/2024 - Scottish Cardiac Audit Programme (SCAP) - Publications - Public Health Scotland.

The Cancer Strategy for Scotland 2023-2033 and Cancer Action Plan for Scotland 2023 – 2026 have a focus on reducing inequities in access to cancer care and cancer outcomes.

The Scottish Government is looking to improve our understanding of outcomes of people with cancer living in rural and island communities. Examples include an independent evaluation of their experiences accessing cancer services, and a research programme on rural healthcare funded by the Chief Scientist Office.

The Scottish Diabetes Survey (SDS) collates data extracted from SCI-Diabetes database submitted by all 14 NHS boards and provides an annual summary of key issues and trends in diabetes care and treatment across Scotland. A link to the survey can be found at: Publications | diabetes in scotland.

Scotland uses the ICD-10 classification for coding diagnoses. Public Health Scotland understand that no changes or updates for any codes in ICD-10 are planned, as work is currently focused on implementation of ICD-11, which in Scotland is likely to be around 2029-2030. It is also understood that there is currently no reference to e-bikes in ICD-11.

Feasibility studies have been conducted on all buildings owned by the Scottish Government to look at options for installing renewable energy and to improve the buildings fabric in line with net zero standards.

The current value of the fleet, as at 31 December 2024, is £2,381,991.

2020 – 2 buildings £4,874,534

2021 – 5 buildings £6,605,939

2022 – 1 building £929,705

2023 – 1 building £290,018

2024 – 0 buildings £0

No energy efficiency projects were implemented in 2024 due to emergency budget controls.

The Scottish Government is working towards our commitment to phase out petrol and diesel cars from our fleet and phase out the need for any new petrol and diesel light commercial vehicles.

The adoption of electric and plug-in hybrid electric vehicles to replace internal combustion engine vehicles aligns with, and supports our decarbonisation policies and targets. Presently, 82% of our overall fleet are zero or ultra-low emission vehicles.

A breakdown of the fleet by total purchase cost by model is provided in the following table.

An individual business case, including socio-economic analysis, is prepared for each route being considered for decarbonisation. These business cases include technical and economic examinations of the case for of different types of rail traction including electric, bi-mode diesel-electric, battery-electric and other independently powered traction technologies such as hydrogen fuel cells have been considered.

The number of cancelled operations under ‘non-clinical/capacity reasons’ is the most granular level of detail that’s provided from PHS’s website, breakdown as follows:

We do not have any current plans to replace these vehicles, however when the vehicles approach the end of their operational life, a vigorous assessment will be conducted by our fleet management team to identify suitable fit for purpose replacements available on the open market. This will include assessing electric and any other zero or ultra-low emission vehicles as potential replacements.